May 13, 2022
Ono Pharmaceutical’s PD-1 inhibitor Opdivo (nivolumab) raked in the largest sales in the Japan pharma market in April, grabbing the crown for the fourth consecutive month, according to a monthly snapshot report released by Encise. Opdivo notched up sales of...read more